BCL6 (B-cell CLL/lymphoma 6) is a nuclear protein, belonging to the BTB/POZ (BR-C, ttk and bab/Pox virus and Zinc finger) domain family of transcription factors. This zinc finger transcription factor has a molecular mass of 95kDa.
Synonyms: Anti-B-cell lymphoma 6 protein antibody produced in rabbit; Anti-BCL-5 antibody produced in rabbit; Anti-BCL-6 antibody produced in rabbit; Anti-LAZ-3 protein antibody produced in rabbit; Anti-Zinc finger and BTB domain-containing protein 27 antibody produced in rabbit; Anti-Zinc finger protein 51 antibody produced in rabbit
MDL Number: MFCD01633044
Storage: -20C
Application: Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.Immunohistochemistry (1 paper)
Biochem Physiol Actions: BCL6 (B-cell CLL/lymphoma 6) is mainly involved in the regulation of B lymphocyte development and growth. Bcl6 acts as a diagnostic marker to identify the level of severity of various diseases. It is predominantly expressed in human cancers such as lymphoid malignancy, breast cancer. In breast cancer, it is associated with the proliferation, anchorage-independent growth, migration, and invasion. It is involved in the BCL6 translocation of primary central nervous system lymphoma, which is further linked with apoptosis process. It is a prime gene in B-cell lymphomagenesis. It has been reported that BCL6 may have corealtion with the preeclampsia.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC